Global Stem Cell and Advanced Technologies Market

Report Overview

Table of Contents

2948.47

Select License Type

£2,948.47	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,533.67	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£5,706.72	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,948.47	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	Global
Published	1 November 2009
Number of Pages	229
Report Delivery	Download
Delivery Lead Time	Immediate
Publisher	Markets&Markets
File Format	-

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Market Estimates and Forecasts

The report categorizes the global stem cell market as follows:
• Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types)
• Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
• Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
• Stem Cell Applications (regenerative medicine - neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 35 company profiles for each of its sub-segments.

Key questions answered

- Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£2,948.47	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£4,533.67	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£5,706.72	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,948.47	Add to Wishlist
Change Currency	GBP EURO USD

Executive summary
MARKET OVERVIEW
Stem cell market dynamics
OPPORTUNITIES
Stem cells product market
OPPORTUNITIES
Stem cells technology market
Stem cells services market
Stem cells applications market
Geographic analysis
Competitive landscape
1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. REPORT DESCRIPTION
1.3. Research METHODOLOGY
1.4. STAKEHOLDERS
2. Summary
3. market overview
3.1. Defining the stem cell market
3.2. Factors influencing the stem cells market
3.3. Stem cell market inhibitors
3.4. Regenerative medicine dominates stem cell applications
3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
3.5.1. U.S. lifts ban on funding
3.5.2. Guidelines for responsible stem cells research
3.5.3. European national policies and legal issues
3.5.4. E.U. funding for stem cells research
3.5.5. Asia Pacific
3.6. Stem cell patent analysis
4. Stem cell market dynamics
4.1. Drivers
4.1.1. Potential of stem cells in regenerative medicine
4.1.2. Key to anti-ageing and prolonging life
4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
4.1.4. EASE of administration
4.1.5. Reduced risk of tissue rejection in transplants
4.1.6. Federal funding for stem cell research
4.2. Restraints
4.2.1. safety issues
4.2.2. Ethical issueS
4.2.3. Insurance issues
4.3. Opportunities
4.3.1. technological innovations
4.3.2. Emerging application as a drug discovery tool
4.3.3. other promising applications
5. Global stem cells product market
5.1. potency-based Stem cell classification
5.2. Adult stem cells
5.2.1. Drivers
5.2.1.1. Applications in cancer and chronic disease treatment
5.2.1.2. Availability of adequate safety & efficacy evidence
5.2.1.3. Technology innovations
5.2.1.4. Lower costs & no ethical issues
5.2.2. Restraints & Opportunities
5.2.2.1. Lower therapeutic potential
5.2.2.2. Need for minimising intervention
5.2.3. Hematopoietic Stem Cells
5.2.3.1. Drivers & Restraints
5.2.3.1.1. Wide range of applications
5.2.3.1.2. Technology developments
5.2.3.1.3. Underused treatment, ineffective GvHD management
5.2.4. Mesenchymal stem cells
5.2.4.1. Drivers
5.2.4.1.1. Huge potential of MSCs
5.2.4.1.2. Advantageous cell type for allogenic transplantation
5.2.4.2. Restraints & Opportunities
5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
5.2.4.3. Potential applications of MSC therapy
5.3. Embryonic stem cells
5.3.1. Drivers & REStraints
5.3.1.1. Immense potential due to pluripotent nature
5.3.1.2. Ban on federal funding lifted
5.3.1.3. Ethical issues and inadequate safety data
5.3.2. Umbilical cord stem cells
5.3.3. Neuronal stem cells
5.3.4. Dental stem cells
5.3.5. Other novel cell types
6. stem cells technology market
6.1. Stem cell production
6.1.1. Somatic nuclear transfer / Therapeutic cloning
6.1.2. IVF (In vitro fertilization)
6.1.3. Isolation & Cell culture
6.2. Expansion & Sub-culture
6.3. Stem cell acquisition
6.3.1. Bone marrow harvest
6.3.2. Apheresis
6.3.3. Umbilical cord blood stem cells acquisition
6.4. Cryopreservation & storage
7. Global stem cells services market
7.1. Stem cell banking
7.1.1. Ethical issues on stem cell banking
7.2. Stem cell acquisition & testing
7.3. Characterization services
7.3.1. HLA typing services
7.3.2. Stem cell custom services
7.3.3. Stem cell custom antibody services
7.4. Molecular biology
7.5. Drug screening & target validation
8. Global stem cells applications market
8.1. Regenerative medicine
8.1.1. Drivers & Restraints
8.1.1.1. Simple and cost-effective production method
8.1.1.2. Public & political support
8.1.1.3. High cost of treatment and low reimbursements
8.1.2. Neurological disorders
8.1.2.1. Alzheimer's disease
8.1.2.2. Parkinson's disease
8.1.2.3. Multiple sclerosis
8.1.2.4. Other diseases
8.1.3. Myocardial Infarction & cardiovascular diseases
8.1.4. Cancer
8.1.4.1. Breast cancer
8.1.4.2. Multiple myeloma
8.1.4.3. Other cancers
8.1.5. Injuries
8.1.6. Incontinence
8.1.7. Diabetes
8.1.8. Orthopedics
8.1.9. Liver disorders
8.1.10. Hematological disorders
8.1.10.1. Other applications
8.1.10.1.1. Limb ischemia
8.1.10.1.2. Systemic lupus
8.2. Drug Discovery & Development
9. Geographic analysis
9.1. North America
9.2. Europe
9.3. Asia
9.4. ROW
10. Competitive landscape
11. Company Profiles
11.1. Advanced Cell Technology Inc
11.2. Aldagen
11.3. Angel Biotechnology
11.4. Angioblast Systems Inc
11.5. Aastrom Biosciences Inc
11.6. Athersys
11.7. Bioheart Inc
11.8. Brainstorm Cell Therapeutics
11.9. California Stem Cell
11.10. Celgene Corporation
11.11. Cellartis AB
11.12. Cellerant Therapeutics
11.13. Cellular Dynamics International, Inc
11.14. Cellular Engineering Technologies
11.15. CordLife Ltd
11.16. Cytori Therapeutics Inc
11.17. ES Cell International
11.18. Gamida Cell Ltd
11.19. Genzyme Corporation
11.20. Geron Corporation Inc
11.21. Global Stem Inc
11.22. Intercytex
11.23. Medistem Inc
11.24. Mesoblast Ltd
11.25. MultiCell Technologies, Inc
11.26. Neostem
11.27. Novocell Inc
11.28. NeuralStem Biopharmaceuticals, Ltd.
11.29. Opexa Therapeutics
11.30. Osiris Therapeutics, Inc
11.31. Plureon Corp
11.32. Pluristem Therapeutics
11.33. ReNeuron, Inc
11.34. StemCells, Inc
11.35. StemLifeLine
11.36. t2cure Gmbh
11.37. TheraVitae
11.38. Thermo Fisher Scientific Inc
11.39. Thermogenesis Corporation
11.40. VetCell Bioscience Ltd
Appendix
U.S. Government policies & guidelines FOR STEM CELL RESEARCH
Patents for united states
Patents for europe
Patents for Japan

List of TableS

SUMMARY TABLE GLOBAL STEM CELL MARKET BY PRODUCT, SERVICES AND TECHNOLOGY 2009-2014 ($ MILLIONS)
Table 1 Global stem cell market by product 2007-2014 ($ Millions)
Table 2 Global adult stem cell market by product 2007-2014 ($ Millions)
Table 3 Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4 Global stem cell technology market 2007-2014 ($ Millions)
Table 5 Global stem cell production market by product 2007-2014 ($ Millions)
Table 6 Global stem cell acquisition market by product 2007-2014 ($ Millions)
Table 7 Global stem cell services market 2007-2014 ($ Millions)
Table 8 Global characterization services market 2007-2014 ($ Millions)
Table 9 GLOBAL STEM CELL APPLICATIONS MARKET BY PRODUCT 2007-2014 ($ MILLIONS)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions)
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions)
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions)
Table 13 Global neurological disorders market by geography 2007-2014 ($ Millions)
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions)
Table 15 Global stem cell therapy market for cancer by geography 2007-2014 ($ Millions)
Table 16 Global stem cell therapy market for Injuries by product 2007-2014 ($ Millions)
Table 17 Global stem cell therapy market for Injuries by geography 2007-2014 ($ Millions)
Table 18 Global stem cell therapy market for Incontinence by geography 2007-2014 ($ Millions)
Table 19 Global stem cell therapy market for Diabetes by geography 2007-2014 ($ Millions)
Table 20 Global stem cell therapy market for Orthopedics by geography 2007-2014 ($ Millions)
Table 21 Global stem cell therapy market for Liver disorders by geography 2007-2014 ($ Millions)
Table 22 Global stem cell therapy market for Hematological disorders by geography 2007-2014 ($ Millions)
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions)
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions)
Table 25 New product, technology, service launch IN THE STEM CELLS MARKET (2008-2009)
Table 26 agreements and collaborations IN THE STEM CELLS MARKET (2008-2009)
Table 27 mergers and acquisition IN THE STEM CELLS MARKET (2008-2009)

List of FIGURES

Figure 1 STEM CELL MARKET SEGMENTATION
Figure 2 FACTORS Driving STEM CELL MARKET GROWTH
Figure 3 FACTORS INHIBITING STEM CELL MARKET GROWTH
Figure 4 Stem cell application market dynamics
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
Figure 6 NIH funding for stem cell research
Figure 7 patent analysis by geography 2006 to 2008
Figure 8 Patent analysis by segment 2006 to 2008
Figure 9 Patent analysis by competitors
Figure 10 Major market growth factors
Figure 11 Stem cell classification on the basis of potency
Figure 12 Stem cell technologies
Figure 13 Prominent focus areas in regenerative medicine
Figure 14 Stem cell transplants types
Figure 15 global Stem cells market by geography ($billion)
Figure 16 North American Stem cells market
Figure 17 european Stem cells market
Figure 18 asian Stem cells market
Figure 19 row Stem cells market
Figure 20 Major segments IN THE global stem cell market (2008-2009)
figure 21 collaborations IN THE global stem cell market (2008-2009)

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Global Stem Cell and Advanced Technologies Market

Global Spreads Market to 2013

Global Solar Thermal Market Analysis and Forecasts to 2020

Global Solar Thermal Market Analysis and Forecasts to 2013

Global Solar Photovoltaic Market Analysis and Forecasts to 2020

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Global Stem Cell and Advanced Technologies Market

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel